UnitedHealth Group Inc.
Operates health insurance plans, pharmacy services, care delivery networks, and healthcare software and analytics across the United States and internationally.
As of Jul 17, 2026
Executive summary
UnitedHealth Group is a diversified healthcare company operating across insurance, care delivery and healthcare technology. The stock is trading with a neutral technical bias at $423.38, having gained 3.0% over the past month and 49.0% over the year, reflecting broad strength in the sector and the company's operational performance. With a market capitalisation of $384 billion, UNH ranks among the largest healthcare businesses globally.
Price history
As of Jul 16, 2026
Performance
+1.16%
-1.92%
+3.00%
+35.58%
+29.99%
+49.02%
As of Jul 16, 2026
Technical indicators
- 56.6
- -1.6Bearish
- 50: 400.4 · 200: 337.41Bullish
- $398.59 / $434.30
Technical Bias
UnitedHealth Group's technical indicators are split: the 50-day moving average above the 200-day supports an upside bias, but MACD momentum is weakening, whilst RSI sits neutral around 56.6. This is a derived technical read showing no clear directional conviction, with the stock trading between support at $398.59 and resistance at $434.30.
A transparent read of the indicators below — not a prediction or recommendation.
As of Jul 16, 2026
Fundamentals
- $384B
- 31.55
- $13.42
- 2.68%
- +2.0%
- $16.1B
- 0.63
- $228.48 – $461.62
- 2.22%
- Jun 15, 2026
- —
As of Jul 17, 2026
Latest news
- SCHD, OKLS: Big ETF InflowsPositive
As of Jul 17, 2026
Short-term outlook
Over the next few weeks, UnitedHealth looks caught between conflicting signals: RSI at 56.6 is neutral, MACD is flagging some bearish momentum, yet the stock still trades above both its 50-day ($400.4) and 200-day ($337.41) averages, a longer-term bullish backdrop. With a 1-month gain of 3.0%, watch $398.59 as support and $434.30 as resistance for near-term direction.
Medium-term outlook
UnitedHealth's revenue growth has slowed to +2.0% year-on-year and its profit margin sits at a modest 2.7%, while a P/E of 31.55 suggests the market is still pricing in more than the current numbers show. A dividend yield of 2.2% offers some income support. With the technical picture reading neutral, the coming quarters may hinge on whether margins can recover from here.
Key risks
- Profit margin sits at a thin 2.7%, leaving little cushion if medical costs or claims trends move against the company.
- Revenue growth of just 2.0% year-on-year is modest, and RBC's commentary points to ongoing pressure in the employer commercial segment.
- At a P/E of 31.55, the stock carries a premium valuation, which can mean sharper downside if growth or margins disappoint.
- The wide 52-week range, from $228.48 to $461.62 against a current price of $423.38, shows the stock has been through significant volatility over the past year.
About UnitedHealth Group Inc.
UnitedHealth Group is a US healthcare company listed on the NYSE under the ticker UNH. Sitting in the healthcare plans industry, it's one of the largest names in the sector, with a market capitalisation of $384 billion reflecting its scale and position among major managed-care and health insurance providers.
The company's key figures give a snapshot of how the market currently views it. A price-to-earnings ratio of 31.55 shows how much investors are paying for each dollar of earnings, while a dividend yield of +2.2% indicates the level of income the stock currently returns to shareholders relative to its share price. Together, these figures offer a starting point for understanding how UnitedHealth Group is valued and rewarded within the broader healthcare plans industry.
AI-assisted research for informational purposes only — not investment advice. Figures are sourced from third-party market data and may be delayed. Do your own research before trading. Your capital is at risk.